What is EDSA's relative strength rating?

EDSA ranks at the 10th percentile over 1 month, 6th percentile over 3 months, 98th percentile over 6 months, 89th percentile over 1 year against the full TickerStance CS+ADRC universe of U.S. equities.

What sector is EDSA in?

EDSA is classified under the Healthcare sector within the Pharmaceutical Products industry per the TickerStance sector-classification pipeline, which maps U.S. equities to GICS-aligned sectors using exchange SIC codes and Massive Finance reference data. Healthcare is currently ranked 3 of 11 sectors by relative strength.

Is EDSA in a leading sector?

Yes — Healthcare ranks at the 82th percentile by sector relative strength, placing it in the leading band (≥ 70th percentile). EDSA benefits from positive sector-level momentum, which historically correlates with above-average stock-level RS performance in the O'Neil / Minervini framework.

How volatile is EDSA?

EDSA currently shows a 20-day average daily range (ADR%) of 12.9%, a 90-day beta versus the S&P 500 of 0.28. An ADR% above 4% indicates an intraday swing-trading eligible name in the Minervini Volatility Contraction Pattern framework. ADR% and ATR% are updated daily; beta is computed over a trailing 90-day window.

Does EDSA have a seasonal pattern?

TickerStance computes EDSA's month-by-month seasonality from its full daily price history: the average and median return for each calendar month, how often that month closed higher, and the best and worst months on record. These are historical frequencies, not forecasts — a strong seasonal month describes what EDSA has tended to do in prior years, not a prediction of what comes next. The full month-by-month heatmap and win-rate table sit higher on this page.

When did EDSA last report earnings?

EDSA most recently filed a 10-Q covering FY22 Q1 with the SEC on 2026-08-13. TickerStance sources earnings data from SEC EDGAR XBRL submissions and updates the fundamentals panel daily. The Pro dossier shows eight quarters of EPS and revenue trend, operating margin history, and a composite earnings-quality rank.

Edesa Biotech, Inc. Common Shares (EDSA) · RS 98

TODAY'S READ · AS OF 2026-08-25

As of 2026-08-25, Edesa Biotech, Inc. Common Shares (EDSA) has a 3-month relative strength percentile of 6 within the TickerStance CS+ADRC universe (~5,000 tickers). Its Power rating (absolute 1–99) is 70. The current market Stance is 52.9 (Neutral). Sector: Healthcare, ranked 3 of 11. Average daily range 12.9%, relative volume 1.36×. TickerStance reports observed regime conditions across the full CS+ADRC universe; band assignment reflects current breadth, momentum, and macro inputs computed at the daily close. Percentile ranks run from 1 (weakest) to 99 (strongest) relative to all universe members on the same date.

RS methodology →

Market-wide RS; lit = leaderboard

Lenses lit

3 month6pctile

6 month98pctile

1 year89pctile

Classic92IBD pctile

LDR59leadership

0 of 5 lenses lit · avg RS pctile 69

✓ADR%12.9%!A/DD!RVOL1.36×!$ Vol$558K

Market backdrop

52.9Neutral

Trend30% weight47.0 Breadth30% weight56.3 Leadership20% weight42.0 Macro20% weight60.3 Full stance breakdown →

§ Seasonality

10y · since 2022

Best monthApr on averageavg +50.65% · 60% win · n 5

Worst monthMay on averageavg -20.97% · 0% win · n 5

EDSA monthly seasonality strip
	Jan	Feb	Mar	Apr	May	Jun	Jul	Aug	Sep	Oct	Nov	Dec
1	EDSA Jan avg: -9.35% median: -10.12% win: 25% σ: 18.98% n: 4 2022-04-12 → 2026-07-31	EDSA Feb avg: 25.53% median: 9.37% win: 75% σ: 42.44% n: 4 2022-04-12 → 2026-07-31	EDSA Mar avg: 25.92% median: 1.09% win: 50% σ: 77.05% n: 4 2022-04-12 → 2026-07-31	EDSA Apr avg: 50.65% median: 6.00% win: 60% σ: 112.22% n: 5 2022-04-12 → 2026-07-31	EDSA May avg: -20.97% median: -15.88% win: 0% σ: 23.03% n: 5 2022-04-12 → 2026-07-31	EDSA Jun avg: -3.54% median: -1.16% win: 40% σ: 13.29% n: 5 2022-04-12 → 2026-07-31	EDSA Jul avg: 2.09% median: 10.84% win: 80% σ: 23.37% n: 5 2022-04-12 → 2026-07-31	EDSA Aug avg: -1.06% median: 3.20% win: 75% σ: 9.37% n: 4 2022-04-12 → 2026-07-31 (current)	EDSA Sep avg: -17.76% median: -13.25% win: 25% σ: 25.99% n: 4 2022-04-12 → 2026-07-31	EDSA Oct avg: -16.49% median: -25.27% win: 25% σ: 18.89% n: 4 2022-04-12 → 2026-07-31	EDSA Nov avg: -9.96% median: -8.19% win: 25% σ: 12.01% n: 4 2022-04-12 → 2026-07-31	EDSA Dec avg: 30.63% median: 9.74% win: 50% σ: 75.41% n: 4 2022-04-12 → 2026-07-31

Evidence · 1 of 3

Receipts behind the read

2 of 5 pass

Leadership

Is it leading?

Relative strength across horizons plus the leadership score.

1m

10

3m

6

6m

98

1y

89

LDR

—

StageWeinstein stage analysis

Stage 2 · Uptrend

Smart money

Who's accumulating?

Accumulation rating, relative volume, U/D ratio, breakout-day proof.

Fundamentals · EDSA

Does the business back the chart?

SEC EDGAR · last filing 10-Q · FY22 Q1 · period end 2021-12-31

4

Fundamentals Growth Rank

How does growth rank vs. the universe?

vs. 4,490 ranked stocks · Sector rank 5

View fundamental leadership map

Laggard

Earnings

Are losses narrowing?

Diluted EPS, last 8 quarters. Loss makers are judged by progress toward breakeven.

Loss widening

−$0.17—

20 Q2

−$0.20—

20 Q3

Evidence · 2 of 3

Sector context

Healthcare · 82th pctile in sector

Top peers · Healthcare

Who else is leading?

ELOX
99RS 3m
FBRX
99RS 3m
MRNA
99RS 3m
EDSA
6RS 3m · you

Sector vs market

Healthcare · 3 of 11

Energy100

Technology91

Healthcare82

Financials

PEERS · Pharmaceutical Products

Same industry, closest relative strength

4 peers · by RS6M

SLSSELLAS Life Sciences Group, Inc. Common Stock98 NVCTNuvectis Pharma, Inc. Common Stock98 TTRXTurn Therapeutics Inc. Common Stock98 RLYBRallybio Corporation Common Stock98

ETF OWNERS

ETFs holding EDSA

EDSA appears in 1 ETF as of Mar 2026: VXF at 0.00% weight, $450K notional.

Held by 1 ETFs · $450K across latest filings · largest weight 0.00% (VXF).

ETFs holding: 1
Total value: $450K
Top 3 concentration: 100.0%
Max weight: VXF · 0.00%

Top 1 by value, from SEC N-PORT-P filings dated Mar 2026.

ETFs holding EDSA ranked by value
ETF	Weight	Value	Δ
VXFVanguard Extended Market ETF	0.00%	$450K	—

As filed in N-PORT — quarterly holdings with up to ~60-day publication lag. Not live positioning.

Public attention · EDSA

Is the crowd watching?

52/ 100 · vs its own 90-day norm▲ 11 vs 7dOverlooked

Weak relative strength and quiet attention. Little to read here either way.

Measures how unusual this name’s public attention is against its own 90-day history — a surprise reading, not a ranking of how watched it is versus other stocks. Intel, not a signal.

News

Reference

Company snapshot

SectorHealthcare

IndustryPharmaceutical Products

SIC2834

Float3.6Mshares

Shares out9.6Mshares

Market cap$42.9MNano Cap

FAQ

Frequently asked questions

What is EDSA's relative strength rating?: EDSA ranks at the 10th percentile over 1 month, 6th percentile over 3 months, 98th percentile over 6 months, 89th percentile over 1 year against the full TickerStance CS+ADRC universe of U.S. equities.
What sector is EDSA in?: EDSA is classified under the Healthcare sector within the Pharmaceutical Products industry per the TickerStance sector-classification pipeline, which maps U.S. equities to GICS-aligned sectors using exchange SIC codes and Massive Finance reference data. Healthcare is currently ranked 3 of 11 sectors by relative strength.
Is EDSA in a leading sector?: Yes — Healthcare ranks at the 82th percentile by sector relative strength, placing it in the leading band (≥ 70th percentile). EDSA benefits from positive sector-level momentum, which historically correlates with above-average stock-level RS performance in the O'Neil / Minervini framework.
How volatile is EDSA?: EDSA currently shows a 20-day average daily range (ADR%) of 12.9%, a 90-day beta versus the S&P 500 of 0.28. An ADR% above 4% indicates an intraday swing-trading eligible name in the Minervini Volatility Contraction Pattern framework. ADR% and ATR% are updated daily; beta is computed over a trailing 90-day window.
Does EDSA have a seasonal pattern?: TickerStance computes EDSA's month-by-month seasonality from its full daily price history: the average and median return for each calendar month, how often that month closed higher, and the best and worst months on record. These are historical frequencies, not forecasts — a strong seasonal month describes what EDSA has tended to do in prior years, not a prediction of what comes next. The full month-by-month heatmap and win-rate table sit higher on this page.

Edesa Biotech, Inc. Common Shares (EDSA) — Stance & relative strength

Lenses lit

Market backdrop

§ Seasonality

Receipts behind the read

Is it leading?

Who's accumulating?

Does the business back the chart?

Are losses narrowing?

Sector context

Who else is leading?

Healthcare · 3 of 11

Same industry, closest relative strength

ETFs holding EDSA

Is the crowd watching?

Company snapshot

Frequently asked questions

How much does it move?

Is revenue confirming?

Are margins expanding?

Share count: tailwind or headwind?

§ Seasonality

Edesa Biotech, Inc. Common Shares (EDSA) — Stance & relative strength

EDSA is not confirmed as a leader. 6 is not yet a leadership-grade RS read, Market Stance is 52.9

Lenses lit

Market backdrop

Receipts behind the read

Is it leading?

Who's accumulating?

Does the business back the chart?

Are losses narrowing?

Sector context

Who else is leading?

Healthcare · 3 of 11

Same industry, closest relative strength

ETFs holding EDSA

Is the crowd watching?

Company snapshot

Frequently asked questions

How much does it move?

Is revenue confirming?

Are margins expanding?

Share count: tailwind or headwind?